<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the first use of the <z:chebi fb="0" ids="26561">ribonucleotide</z:chebi> reductase M1 subunit (RRM1) locus as a marker to assist in defining genetic rearrangements at 11p15 </plain></SENT>
<SENT sid="1" pm="."><plain>Our sample consisted of 21 Wilms' <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from 18 patients, and one <z:mp ids='MP_0009044'>adrenal adenoma</z:mp> from a patient with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, preexisting chromosome 11 maps being refined by the use of the RRM1 locus in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="2" pm="."><plain>Significantly, one <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> showed loss of heterozygosity at the RRM1 locus only, whereas the <z:mp ids='MP_0009044'>adrenal adenoma</z:mp> showed a maintenance of heterozygosity at the RRM1 locus, loss having been previously demonstrated at the c-Ha-ras locus </plain></SENT>
<SENT sid="3" pm="."><plain>The relevance of this finding to the location of one or more disease-associated loci at 11p15 is discussed </plain></SENT>
</text></document>